Characteristics | Â | Â | N = 75 |
---|---|---|---|
Age (year)* | Â | Â | 66 (30-86) |
Sex (%) | Â | Male | 48 (64.0) |
 |  | Female | 27 (36.0) |
BMI* | Â | Â | 21.1 (14.4-34.9) |
ASA (%) | Â | 1 | 25 (33.3) |
 |  | 2-3 | 50 (66.7) |
Tumor location (%) | Right | A | 6 (8.0) |
 |  | T | 10 (13.3) |
 | Left | D | 7 (9.3) |
 |  | S | 28 (37.3) |
 |  | RS | 17 (22.7) |
 |  | Ra | 6 (8.0) |
 |  | Rb | 1 (1.3) |
T factor (%) | Â | 2 | 1 (1.3) |
 |  | 3 | 40 (53.3) |
 |  | 4a | 26 (34.7) |
 |  | 4b | 8 (10.7) |
N factor (%) | Â | 0 | 30 (40.0) |
 |  | 1 | 23 (30.7) |
 |  | 2 | 22 (29.3) |
TNM stage (%) | Â | I | 1 (1.3) |
 |  | IIA/IIB/IIC | 10/12/4 (34.7) |
 |  | IIIA/IIIB/IIIC | 0/18/8 (34.7) |
 |  | IVA/IVB | 21/1 (29.3) |
TSR (%) | Â | Â | 73/75 (97.3) |
CSR (%) | Â | Â | 72/75 (96.0) |
Interval to surgery (day)* | Â | Â | 13 (0-62) |
Synchronous cancers (%) | Â | Â | 11 (14.7) |